UBS Group
SZYM

UBS Group’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

UBS Group’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$1K – 8679
2015
Q4 		$1K Hold
200
– – ﹤0.01% 8248
2015
Q3 		$1K Hold
200
– – ﹤0.01% 8310
2015
Q2 		$1K Hold
200
– – ﹤0.01% 8390
2015
Q1 		$1K Hold
200
– – ﹤0.01% 8658
2014
Q4 		$1K Buy
+200
New +$875 ﹤0.01% 9609

UBS Group's SZYM Position: Q2 2016 in Review

UBS Group sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 215,369 shares — an estimated $437K sold.

UBS Group first reported a position in SZYM in Q4 2014 and held it in 6 quarters. The position peaked at $801K in Q2 2015. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • UBS Group reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • UBS Group sold 215,369 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $437K.
  • UBS Group first reported a position in SOLAZYME INC COM STK (DE) in Q4 2014 and held it in 6 quarters.
  • UBS Group's SOLAZYME INC COM STK (DE) position peaked at $801K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on UBS Group's 13F filing for Q2 2016, filed 12 Aug 2016.